J&J sells breast care unit to Devicor
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson's Ethicon Endo-Surgery unit completes the divestiture of its breast care business to Devicor Medical Products on July 12. Devicor's acquisition of the vacuum-assisted breast biopsy device maker, for undisclosed terms, includes the flagship Mammotome breast biopsy system (1"The Gray Sheet" April 5, 2010)
You may also be interested in...
J&J/Ethicon Endo-Surgery Weighs Breast Care Divestiture To Devicor
Devicor Medical Products is seeking a foothold in the device market with its proposed acquisition of Johnson & Johnson/Ethicon Endo-Surgery's breast care business, the company announced March 30
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.